Kymera Therapeutics financial statements

키메라 테라퓨틱스NASDAQ:KYMR · Nasdaq · Healthcare · sector #17
$108.35+2.24%
2026-10-07 close · prelim

Kymera Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $47M. 2024 operating profit was −$262M.

Reported results

Kymera Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy